Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,836 | 46,881 | 93,938 | 113,079 | 120,150 |
| Marketable Securities | 29,868 | 40,725 | N/A | N/A | N/A |
| Receivables | 8,680 | 10,472 | 11,314 | 9,444 | 9,605 |
| Inventories | 13,063 | 13,218 | 11,373 | 9,014 | 6,093 |
| TOTAL | $111,744 | $119,894 | $126,466 | $140,814 | $145,660 |
| Non-Current Assets | |||||
| PPE Net | 10,492 | 9,390 | 7,588 | 7,487 | 6,492 |
| Intangibles | 38,704 | 39,061 | 39,222 | 39,412 | 39,636 |
| Other Non-Current Assets | 15,517 | 15,918 | 13,852 | 3,194 | 3,623 |
| TOTAL | $64,713 | $64,369 | $60,662 | $50,093 | $49,751 |
| Total Assets | $176,457 | $184,263 | $187,128 | $190,907 | $195,411 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,172 | 13,372 | 11,518 | 9,435 | 4,071 |
| Accrued Expenses | 14,037 | 11,503 | 12,138 | 13,491 | 8,596 |
| TOTAL | $31,682 | $33,783 | $31,736 | $27,682 | $17,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,714 | 42,565 | 32,576 | 32,471 | 32,363 |
| Deferred Revenues | 5,876 | 5,315 | 4,892 | 4,484 | 4,354 |
| Other Non-Current Liabilities | 14,679 | 14,665 | 14,261 | 7,850 | 6,824 |
| TOTAL | $69,687 | $59,630 | $48,840 | $41,874 | $40,719 |
| Total Liabilities | $101,369 | $93,413 | $80,576 | $69,556 | $58,019 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,956 | 37,892 | 37,590 | 37,475 | 37,208 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -147,873 | -130,001 | -112,506 | -96,107 | -78,434 |
| Other shareholders' equity | -66 | -92 | 0 | 0 | 0 |
| TOTAL | $75,088 | $90,850 | $106,552 | $121,351 | $137,392 |
| Total Liabilities And Equity | $176,457 | $184,263 | $187,128 | $190,907 | $195,411 |